Provided by Tiger Trade Technology Pte. Ltd.

Penumbra

325.18
+1.420.44%
Post-market: 325.180.00000.00%16:10 EDT
Volume:167.12K
Turnover:54.34M
Market Cap:12.81B
PE:79.94
High:325.66
Open:323.87
Low:323.87
Close:323.76
52wk High:362.41
52wk Low:221.26
Shares:39.39M
Float Shares:38.19M
Volume Ratio:0.74
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.07
EPS(LYR):4.52
ROE:11.37%
ROA:6.42%
PB:8.37
PE(LYR):71.94

Loading ...

Penumbra STORM-PE trial shows better 90-day function with thrombectomy vs anticoagulation

Reuters
·
Apr 13

Is It Too Late To Consider Penumbra (PEN) After A Strong 1-Year Share Price Run?

Simply Wall St.
·
Apr 10

Penumbra director Harpreet Grewal disposes of USD 32,822 common shares

Reuters
·
Apr 07

Penumbra price target lowered to $345 from $360 at Evercore ISI

TIPRANKS
·
Apr 06

FTC issued Second Request to Penumbra, Boston Scientific over merger review

TIPRANKS
·
Mar 31

Bybit Launches Peru-Exclusive Promotion Offering Up to 17 USDT for PEN Deposits and Trading

prnewswire
·
Mar 24

Should Penumbra’s Clinical Momentum and Shifting Ownership Mix Require Action From Penumbra (PEN) Investors?

Simply Wall St.
·
Mar 19

Penumbra CFO Maggie Yuen Disposes of Common Shares

Reuters
·
Mar 05

Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future

Simply Wall St.
·
Mar 04

Boston Scientific signs $3 billion revolving credit agreement with Wells Fargo and lenders

Reuters
·
Feb 27

Penumbra Seen as 'Strategic and Financial Fit' for Boston Scientific, RBC Says

MT Newswires Live
·
Feb 27

Penumbra Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Feb 26

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)

TIPRANKS
·
Feb 26

Hold Rating Maintained on Penumbra Amid Strong Results but Limited Visibility Ahead of Boston Scientific Acquisition

TIPRANKS
·
Feb 26

Penumbra price target raised to $360 from $340 at Evercore ISI

TIPRANKS
·
Feb 26

Medical equipment maker Penumbra beats Q4 revenue expectations

Reuters
·
Feb 26

Penumbra reports Q4 adjusted EPS $1.18, consensus $1.11

TIPRANKS
·
Feb 26

Penumbra Q4 Adj. EPS $1.18 Beats $1.11 Estimate, Sales $385.385M Beat $366.795M Estimate

Benzinga Earnings
·
Feb 26

Penumbra Q4 revenue rises 22.1% to USD 385.4 million

Reuters
·
Feb 26

BRIEF-Penumbra Q4 Revenue USD 385.385 Million Vs. IBES Estimate USD 366.8 Million

Reuters
·
Feb 26